issuances of our securities could dilute current stockholders’ ownership.
of December 31, 2018, we had 41.7 million shares of our common stock issuable upon conversion of our Series A Convertible Preferred
Stock bearing dividends at a rate of six percent (6.0%) per annum, which are cumulative and accrue daily from the date of issuance
on the $1,000 stated value. Such dividends will not be paid in cash, except in connection with any liquidation, dissolution or
winding up of the Company or any redemption of the Series A Convertible Preferred Stock. Instead, the value of the accrued dividends
is added to the liquidation preference of the Series A Convertible Preferred Stock and will increase the number of shares of common
stock issuable upon conversion, which will dilute the ownership of our common stockholders.
addition, a significant number of shares of our common stock are subject to warrants, stock options and stock appreciation rights,
and we may request the ability to issue additional such securities. We may also decide to raise additional funds through public
or private debt or equity financing to fund our operations. While we cannot predict the effect, if any, that future exercises
of warrants or future sales of debt, our common stock, other equity securities or securities convertible into our common stock
or other equity securities or the availability of any of the foregoing for future sale, will have on the market price of our common
stock, it is likely that sales of substantial amounts of our common stock (including shares issued upon the exercise of warrants,
stock options, stock appreciation rights or the conversion of any convertible securities outstanding now or in the future, including
the Series A Convertible Preferred Shares), will dilute the ownership of our existing stockholders and that the perception that
such sales could occur, will adversely affect prevailing market prices for our common stock.
the Series A Convertible Preferred Shares rank senior to our common stock as to distributions and payments upon the liquidation,
dissolution and winding up of the Company. No such distributions or payments upon the liquidation, dissolution and winding up
of the Company may be made to holders of common stock unless and until the holders of the Series A Convertible Preferred Shares
have received the stated value of $1,000 per share plus any accrued and unpaid dividends. Until all Series A Convertible Preferred
Shares have been converted or redeemed, no dividends may be paid on the common stock without the express written consent of the
holders of a majority of the outstanding Series A Convertible Preferred Shares. In the event that dividends or other distributions
of assets are made or paid by the Company to the holders of the common stock, the holders of Series A Convertible Preferred Shares
are entitled to participate in such dividend or distribution on an as-converted basis. Any such distributions or payments upon
the liquidation, dissolution or winding up of the Company may dilute the ownership interests of our existing stockholders.
have never paid dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable future.
have paid no cash dividends on any of our classes of capital stock to date and we currently intend to retain our future earnings
to fund the development and growth of our business. In addition, the terms of our loan agreement prohibit us from declaring dividends
without the prior consent of our lender. As a result, capital appreciation, if any, of our common stock will be an investor’s
sole source of gain for the foreseeable future.
certificate of incorporation and bylaws, Delaware law, and one of our collaboration agreements contain provisions that could discourage
certificate of incorporation and bylaws and Delaware law contain provisions that might enable our management to resist a takeover.
These provisions may:
delay or prevent a change in the control of our company or a change in our management;|
affect the voting power of holders of common stock; and |
the price that investors might be willing to pay in the future for shares of our common stock. |
addition, our collaboration agreement with Biosense Webster contains provisions that may similarly discourage a takeover and negatively
affect our share price as described above.
regulation of corporate governance and public disclosure may result in additional expenses and continuing uncertainty.
laws, regulations and standards relating to corporate governance and public disclosure, including the new SEC regulations such
as the Dodd-Frank Wall Street Reform and Consumer Protection Act have in the past created uncertainty for public companies. We
continue to evaluate and monitor developments with respect to new and proposed rules and cannot predict or estimate the amount
of the additional compliance costs we may incur or the timing of such costs. These new or changed laws, regulations and standards
are subject to varying interpretations, in many cases due to their lack of specificity, and as a result, their application in
practice may evolve over time as new guidance is provided by courts and regulatory and governing bodies. This could result in
uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.
Maintaining appropriate standards of corporate governance and public disclosure may result in increased general and administrative
expense and a diversion of management time and attention from revenue-generating activities to compliance activities. In addition,
if we fail to comply with new or changed laws, regulations and standards, regulatory authorities may initiate legal proceedings
against us and our business and reputation may be harmed.